| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.03 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |